Options
Induction therapy with intercalated TKI and chemotherapy in NSCLC with activating EGFR mutation in stages II-IIIB: Neolntercal
ISSN
2296-5262
2296-5270
Date Issued
2015
Author(s)
Griesinger, Frank
Sebastian, Martin
Serke, Monika Heidi
Buettner, Reinhardt
Waller, C.
Reinmuth, Nils
Graeven, Ullrich
Lueers, Anne C.
Radke, Susanne M.
Karatas, Aysun
Heukamp, Lukas Carl
Tiemann, Markus